Combining neuroprotection with EVT: dream or close to reality

Based on the results of recently published studies on neuroprotection, Prof. Mayank GOYAL answers the following questions:

• Is nerinetide safe and effective in acute ischemic stroke patients with LVO undergoing EVT?
• What variables on 24-hour follow-up imaging, other than total infarct volume, influence outcome?
• Is there a ceiling effect when predicting outcomes in acute ischemic stroke patients undergoing EVT and what are the most important predictors?
• What are predictors of infarct progression rate in acute ischemic stroke patients undergoing EVT?
• What are the optimal EVT imaging selection criteria in the late time window?